Ishikawa, K.; Nakamura, T.; Kawai, F.; Ota, E.; Mori, N.
Correction: Ishikawa et al. Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers 2024, 16, 1934. Cancers 2024, 16, 2274.
https://doi.org/10.3390/cancers16122274
AMA Style
Ishikawa K, Nakamura T, Kawai F, Ota E, Mori N.
Correction: Ishikawa et al. Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers 2024, 16, 1934. Cancers. 2024; 16(12):2274.
https://doi.org/10.3390/cancers16122274
Chicago/Turabian Style
Ishikawa, Kazuhiro, Tomoaki Nakamura, Fujimi Kawai, Erika Ota, and Nobuyoshi Mori.
2024. "Correction: Ishikawa et al. Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers 2024, 16, 1934" Cancers 16, no. 12: 2274.
https://doi.org/10.3390/cancers16122274
APA Style
Ishikawa, K., Nakamura, T., Kawai, F., Ota, E., & Mori, N.
(2024). Correction: Ishikawa et al. Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients. Cancers 2024, 16, 1934. Cancers, 16(12), 2274.
https://doi.org/10.3390/cancers16122274